Click a link below to view the mailing archive as if it had been sent to you.
| 2020-04-30 12:15 | | AstraZeneca, racing past rivals, throws its weight behind Oxford's COVID-19 vaccine and more... |
| 2020-04-30 00:15 | | Gilead’s Antiviral Remdesivir Had A Good Day - But It’s Still Not Clear How Effective It Is Against COVID-19 and more... |
| 2020-04-29 12:15 | | Gilead says critical study of Covid-19 drug shows patients are responding to treatment and more... |
| 2020-04-29 00:15 | | FDA, EU authorities update guidance on clinical trials during COVID-19 and more... |
| 2020-04-28 12:15 | | Merck, slower than its peers, edges into COVID-19 fight and more... |
| 2020-04-28 00:15 | | FDA Approves Neurocrine Biosciences' Parkinson's Drug and more... |
| 2020-04-27 12:15 | | AACR: Roche's Tecentriq, added to Cotellic and Zelboraf, stalls melanoma progression and more... |
| 2020-04-27 00:15 | | 7 Bold Predictions for Medtech After COVID-19 and more... |
| 2020-04-26 00:15 | | A Vaccine Candidate Protects Non-Human Primates From SARS-CoV-2 Infection and more... |
| 2020-04-25 12:15 | | FDA warns on safety threat posed by 2 drugs initially backed by Trump for Covid-19 — following an emergency use authorization and more... |
| 2020-04-24 12:15 | | Johnson & Johnson sets stage for COVID-19 shot rollout with 'first in a series' manufacturing deal and more... |
| 2020-04-24 00:15 | | One COVID-19 opportunity for pharma? A chance to bolster its reputation, Lilly CEO says and more... |
| 2020-04-23 12:15 | | Thermo Fisher and Roche enjoy COVID-19 diagnostic tailwinds, but warn of routine testing declines and more... |
| 2020-04-23 00:15 | | New Developments In Producing A COVID-19 Vaccine And Identifying High-Risk Individuals and more... |
| 2020-04-22 12:15 | | Biogen shares fall as company pushes back Alzheimer’s drug filing and more... |
| 2020-04-22 00:15 | | Veterans With COVID-19 Given Trump-Touted Hydroxychloroquine Showed No Benefits, Study Finds and more... |
| 2020-04-21 12:15 | | Life science companies combine to form COVID-19 research database and more... |
| 2020-04-21 00:15 | | Exelixis lands PhIII kidney cancer win with Bristol Myers in their hunt for $4 billion |
| 2020-04-20 12:15 | | Incyte nabs 2nd ever approval ahead of schedule as FDA insists it can still review on time and more... |
| 2020-04-20 00:15 | | Boston Scientific Begins Selling Low-Cost Ventilator Alternative and more... |
| 2020-04-19 00:15 | | Scientists tap CRISPR’s search-and-detect skills to create a rapid Covid-19 test and more... |
| 2020-04-18 00:15 | | Genentech, Novo Nordisk and AbbVie top the list of best workplaces in biopharma and more... |
| 2020-04-17 12:15 | | NIH partners with 16 drug companies in hopes of accelerating Covid-19 treatments and vaccines and more... |
| 2020-04-17 00:15 | | By June, Abbott Labs Rapid Coronavirus Test To Reach ‘General Population’ and more... |
| 2020-04-16 12:15 | | Mylan's Robert Coury returns to exec chairman role amid pandemic, delayed merger and more... |
| 2020-04-16 00:15 | | Harvard professors call on FDA to maintain review standards amid COVID-19 and more... |
| 2020-04-15 12:15 | | J&J eyes 'imminent' coronavirus vaccine production, aims for a billion doses worldwide and more... |
| 2020-04-15 00:15 | | Cerevance Nabs $45 Million in Funding to Support CNS Disease Research and more... |
| 2020-04-14 12:15 | | Sanofi, GSK tie up for COVID-19 vaccine work with eyes on possible 2021 rollout and more... |
| 2020-04-14 00:15 | | First study of Gilead’s remdesivir in COVID-19 reveals little and more... |
| 2020-04-13 12:15 | | AstraZeneca stops lung cancer trial early, after star drug Tagrisso induces 'overwhelming' efficacy and more... |
| 2020-04-12 00:15 | | Early Look at Gilead Sciences' Experimental Coronavirus Treatment Disappoints and more... |
| 2020-04-10 12:15 | | Data for Regeneron arthritis drug in coronavirus could come in weeks and more... |
| 2020-04-10 00:15 | | FDA Approves Pfizer's Braftovi Plus Cetuximab for Colorectal Cancer with BRAF Mutations and more... |
| 2020-04-09 12:15 | | Pfizer finds COVID-19 drug candidate, plots summer testing and more... |
| 2020-04-09 00:15 | | FDA Cautions Antibody Test Developers Against Falsely Claiming Tests are Authorized and more... |
| 2020-04-08 12:15 | | Roche’s risdiplam delay a relief for SMA rivals Biogen and Novartis—for now: analyst and more... |
| 2020-04-08 00:15 | | Sage to lay off half of workforce in cost-cutting retrenchment and more... |
| 2020-04-07 12:15 | | Eli Lilly lowers insulin costs as coronavirus crisis deepens and more... |
| 2020-04-07 00:15 | | White House, experts clash over use of drug for coronavirus and more... |
| 2020-04-06 12:15 | | Ex-FDA chief says regulator needs to up pace on COVID-19 drugs and more... |
| 2020-04-06 00:15 | | Are Amarin's Blockbuster Dreams Over? and more... |
| 2020-04-05 00:15 | | Ex-FDA chief warns ‘parts of our lives’ will stay shut down without a coronavirus drug by fall and more... |
| 2020-04-04 00:15 | | Opioid supply crunch for U.S. coronavirus patients prompts appeal to relax limits and more... |
| 2020-04-03 12:15 | | Zentalis Pharmaceuticals Raises $165 Million in Expanded IPO and more... |
| 2020-04-03 00:15 | | Merck scores new advance on tumor-agnostic front as Keytruda beat chemo-based regimens in a type of colorectal cancer and more... |
| 2020-04-02 12:15 | | A Covid-19 threat to business acquisitions and more... |
| 2020-04-02 00:15 | | COVID-19 Could Hurt Orthopedics Companies in More Ways than One |
| 2020-04-01 12:15 | | White House pressures FDA on unproven Japanese drug and more... |
| 2020-04-01 00:15 | | Experts weigh in on vaccine prospects as dozens of COVID-19 projects race ahead and more... |
